1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone
C19H30N6O3 — CID 167771813
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone
1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone (PubChem CID 167771813) has the molecular formula C19H30N6O3 and a molecular weight of 390.49 g/mol. Its IUPAC name is 1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone.
Molecular Properties
| Compound Name | 1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone |
|---|---|
| PubChem CID | 167771813 |
| Molecular Formula | C19H30N6O3 |
| Molecular Weight | 390.49 g/mol |
| Exact Mass | 390.24 |
| IUPAC Name | 1-[9-(3-methylcyclohexanecarbonyl)-1-oxa-4,9-diazaspiro[5.5]undecan-4-yl]-2-(tetrazol-1-yl)ethanone |
| SMILES | CC1CCCC(C(=O)N2CCC3(CC2)CN(C(=O)Cn2cnnn2)CCO3)C1 |
| InChI | InChI=1S/C19H30N6O3/c1-15-3-2-4-16(11-15)18(27)23-7-5-19(6-8-23)13-24(9-10-28-19)17(26)12-25-14-20-21-22-25/h14-16H,2-13H2,1H3 |
| InChIKey | IADWOEJXDVPNOZ-UHFFFAOYSA-N |
| XLogP | 0.72 |
| TPSA | 93.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.49 |
| LogP ≤ 5 | 0.72 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167771813 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.